Showing results (11-20 of 24) with videos related to
Sort By:
Pageof 3
The Journal of Biological Chemistry|October 17, 1998
Internalization of the lymphocytic surface protein CD22 is controlled by a novel membrane proximal cytoplasmic motifC H Chan, J Wang, R R French, et al.Methods in Molecular Medicine|February 22, 2011
The application of monoclonal antibodies in the treatment of lymphomaM J Glennie, J Honeychurch, R R French, et al.Nature Medicine|May 6, 1999
CD40 antibody evokes a cytotoxic T-cell response that eradicates lymphoma and bypasses T-cell helpR R French, H T Chan, A L Tutt, et al.Cancer Research|May 1, 1991
Cooperative mixtures of bispecific F(ab')2 antibodies for delivering saporin to lymphoma in vitro and in vivoR R French, A E Courtenay, S Ingamells, et al.Leukemia Research|July 1, 1996
Response of B-cell lymphoma to a combination of bispecific antibodies and saporinR R French, A J Bell, T J Hamblin, et al.Lancet (London, England)|July 22, 1995
Treatment of B-cell lymphomas with combination of bispecific antibodies and saporinR R French, T J Hamblin, A J Bell, et al.Blood|June 25, 1999
The importance of antibody-specificity in determining successful radioimmunotherapy of B-cell lymphomaT M Illidge, M S Cragg, H M McBride, et al.Cancer Research|July 1, 1993
Delivery of saporin to human B-cell lymphoma using bispecific antibody: targeting via CD22 but not CD19, CD37, or immunoglobulin results in efficient killingM A Bonardi, R R French, P Amlot, et al.British Journal of Cancer|May 1, 1995
Delivery of the ribosome-inactivating protein, gelonin, to lymphoma cells via CD22 and CD38 using bispecific antibodiesR R French, C A Penney, A C Browning, et al.Therapeutic Immunology|August 1, 1995
The development of anti-CD79 monoclonal antibodies for treatment of B-cell neoplastic diseaseL Zhang, R R French, H T Chan, et al.Pageof 3